Risks and benefits of renal artery stenting in fibromuscular dysplasia: Lessons from the ARCADIA-POL study.

MLA

Kądziela, Jacek, et al. “Risks and Benefits of Renal Artery Stenting in Fibromuscular Dysplasia: Lessons from the ARCADIA-POL Study.” Vascular Medicine (London, England), vol. 29, no. 1, Feb. 2024, pp. 50–57. EBSCOhost, https://doi.org/10.1177/1358863X231210523.

APA

Kądziela, J., Jóźwik-Plebanek, K., Pappaccogli, M., van der Niepen, P., Prejbisz, A., Dobrowolski, P., Michałowska, I., Talarowska, P., Warchoł-Celińska, E., Stryczyński, Ł., Krekora, J., Andziak, P., Szczerbo-Trojanowska, M., Maciąg, R., Sterliński, I., Witkowski, A., Januszewicz, A., Adlam, D., Januszewicz, M., & Persu, A. (2024). Risks and benefits of renal artery stenting in fibromuscular dysplasia: Lessons from the ARCADIA-POL study. Vascular Medicine (London, England), 29(1), 50–57. https://doi.org/10.1177/1358863X231210523

Chicago

Kądziela, Jacek, Katarzyna Jóźwik-Plebanek, Marco Pappaccogli, Patricia van der Niepen, Aleksander Prejbisz, Piotr Dobrowolski, Ilona Michałowska, et al. 2024. “Risks and Benefits of Renal Artery Stenting in Fibromuscular Dysplasia: Lessons from the ARCADIA-POL Study.” Vascular Medicine (London, England) 29 (1): 50–57. doi:10.1177/1358863X231210523.